{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:37:44Z","timestamp":1788914264480,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470638"],"award-info":[{"award-number":["81470638"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","award":["2016YFC0904800"],"award-info":[{"award-number":["2016YFC0904800"]}],"id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["19YF1439300"],"award-info":[{"award-number":["19YF1439300"]}]},{"name":"Shanghai Jiao Tong University Translation Medicine Cross Research Fund Project)","award":["ZH2018QNA24"],"award-info":[{"award-number":["ZH2018QNA24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12886-019-1131-0","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T09:02:33Z","timestamp":1559293353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment"],"prefix":"10.1186","volume":"19","author":[{"given":"Yupeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-3133","authenticated-orcid":false,"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"issue":"9735","key":"1131_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124\u201336.","journal-title":"Lancet"},{"issue":"7","key":"1131_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ophtha.2015.03.024","volume":"122","author":"A Das","year":"2015","unstructured":"Das A, McGuire PG, Rangasamy S. Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology. 2015;122(7):1375\u201394.","journal-title":"Ophthalmology"},{"issue":"3","key":"1131_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"6","key":"1131_CR4","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325.","journal-title":"Diabetes"},{"issue":"22","key":"1131_CR5","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1001\/jama.2014.2536","volume":"311","author":"LM Jampol","year":"2014","unstructured":"Jampol LM, Bressler NM, Glassman AR. Revolution to a new standard treatment of diabetic macular edema. JAMA. 2014;311(22):2269\u201370.","journal-title":"JAMA"},{"issue":"2","key":"1131_CR6","first-page":"e121","volume":"164","author":"E Pacella","year":"2013","unstructured":"Pacella E, La Torre G, Impallara D, Malarska K, Turchetti P, Brillante C, et al. Efficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-up. Clin Ter. 2013;164(2):e121\u20136.","journal-title":"Clin Ter"},{"issue":"8","key":"1131_CR7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.ophtha.2007.12.004","volume":"115","author":"DJ Browning","year":"2008","unstructured":"Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, et al. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology. 2008;115(8):1366\u201371.e1.","journal-title":"Ophthalmology"},{"issue":"5","key":"1131_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ophtha.2013.11.041","volume":"121","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology. 2014;121(5):1045\u201353.","journal-title":"Ophthalmology"},{"issue":"10","key":"1131_CR9","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","volume":"120","author":"DM Brown","year":"2013","unstructured":"Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology. 2013;120(10):2013\u201322.","journal-title":"Ophthalmology"},{"issue":"6","key":"1131_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/IAE.0b013e3182349686","volume":"32","author":"SH Byeon","year":"2012","unstructured":"Byeon SH, Chu YK, Hong YT, Kim M, Kang HM, Kwon OW. New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography. Retina (Philadelphia, Pa). 2012;32(6):1087\u201399.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"10","key":"1131_CR11","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1167\/iovs.14-15020","volume":"55","author":"M Mishra","year":"2014","unstructured":"Mishra M, Kowluru RA. Retinal mitochondrial DNA mismatch repair in the development of diabetic retinopathy, and its continued progression after termination of hyperglycemia. Invest Ophthalmol Vis Sci. 2014;55(10):6960\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1131_CR12","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1111\/aos.13520","volume":"96","author":"SG Prager","year":"2018","unstructured":"Prager SG, Lammer J, Mitsch C, Hafner J, Pemp B, Scholda C, et al. Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone. Acta Ophthalmol. 2018;96(2):e195\u2013200.","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"1131_CR13","doi-asserted-by":"publisher","first-page":"e70544","DOI":"10.1371\/journal.pone.0070544","volume":"8","author":"Q Wang","year":"2013","unstructured":"Wang Q, Li T, Wu Z, Wu Q, Ke X, Luo D, et al. Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo. PLoS One. 2013;8(8):e70544.","journal-title":"PLoS One"},{"issue":"9","key":"1131_CR14","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","volume":"121","author":"X Li","year":"2014","unstructured":"Li X, Xu G, Wang Y, Xu X, Liu X, Tang S, et al. Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study. Ophthalmology. 2014;121(9):1740\u20137.","journal-title":"Ophthalmology"},{"key":"1131_CR15","doi-asserted-by":"publisher","first-page":"38326","DOI":"10.1038\/srep38326","volume":"6","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Yang X, Jin H, Qu Y, Zhang Y, Liu K, et al. Changes in retinal nerve Fiber layer thickness after multiple injections of novel VEGF decoy receptor Conbercept for various retinal diseases. Sci Rep. 2016;6:38326.","journal-title":"Sci Rep"},{"issue":"8","key":"1131_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.ophtha.2009.12.044","volume":"117","author":"E Midena","year":"2010","unstructured":"Midena E, Vujosevic S, Cavarzeran F, Microperimetry Study G. Normal values for fundus perimetry with the microperimeter MP1. Ophthalmology. 2010;117(8):1571\u20136, 6 e1.","journal-title":"Ophthalmology"},{"issue":"11","key":"1131_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/bjo.2007.119685","volume":"91","author":"E Midena","year":"2007","unstructured":"Midena E, Vujosevic S, Convento E, Manfre A, Cavarzeran F, Pilotto E. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration. Br J Ophthalmol. 2007;91(11):1499\u2013503.","journal-title":"Br J Ophthalmol"},{"issue":"13","key":"1131_CR18","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1167\/iovs.12-10290","volume":"53","author":"KV Chalam","year":"2012","unstructured":"Chalam KV, Bressler SB, Edwards AR, Berger BB, Bressler NM, Glassman AR, et al. Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(13):8154\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1131_CR19","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/IAE.0000000000000900","volume":"36","author":"L Su","year":"2016","unstructured":"Su L, Ren X, Wei H, Zhao L, Zhang X, Liu J, et al. Intravitreal conbercept (KH902) for surgical treatment of severe proliferative diabetic retinopathy. Retina (Philadelphia, Pa). 2016;36(5):938\u201343.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"3","key":"1131_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/dom.12008","volume":"15","author":"X Chen","year":"2013","unstructured":"Chen X, Li J, Li M, Zeng M, Li T, Xiao W, et al. KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF. Diabetes Obes Metab. 2013;15(3):224\u201333.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1131_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2008.09.042","volume":"116","author":"M Bolz","year":"2009","unstructured":"Bolz M, Ritter M, Schneider M, Simader C, Scholda C, Schmidt-Erfurth U. A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema. Ophthalmology. 2009;116(1):66\u201372.","journal-title":"Ophthalmology"},{"issue":"4","key":"1131_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1172\/JCI2425","volume":"102","author":"AJ Barber","year":"1998","unstructured":"Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102(4):783\u201391.","journal-title":"J Clin Invest"},{"issue":"10","key":"1131_CR23","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.ophtha.2009.06.066","volume":"116","author":"SH Byeon","year":"2009","unstructured":"Byeon SH, Chu YK, Lee H, Lee SY, Kwon OW. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. Ophthalmology. 2009;116(10):1949\u201359 e8.","journal-title":"Ophthalmology"},{"issue":"3","key":"1131_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000438793","volume":"54","author":"AN Tejerina","year":"2015","unstructured":"Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, et al. One-year progression of diabetic subclinical macular edema in eyes with mild nonproliferative diabetic retinopathy: location of the increase in retinal thickness. Ophthalmic Res. 2015;54(3):118\u201323.","journal-title":"Ophthalmic Res"},{"issue":"2","key":"1131_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1167\/iovs.03-0557","volume":"45","author":"QD Nguyen","year":"2004","unstructured":"Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2004;45(2):617\u201324.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1131_CR26","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/IAE.0000000000000923","volume":"36","author":"A Ebneter","year":"2016","unstructured":"Ebneter A, Wolf S, Abhishek J, Zinkernagel MS. Retinal layer response to ranibizumab during treatment of diabetic macular edema: thinner is not always better. Retina (Philadelphia, Pa). 2016;36(7):1314\u201323.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"13","key":"1131_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Diabetic Retinopathy Clinical Research N, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193\u2013203.","journal-title":"N Engl J Med"},{"issue":"1","key":"1131_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2004.07.050","volume":"139","author":"R Ray","year":"2005","unstructured":"Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol. 2005;139(1):18\u201329.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1131_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/IAE.0b013e3181e095a4","volume":"31","author":"J Lammer","year":"2011","unstructured":"Lammer J, Scholda C, Prunte C, Benesch T, Schmidt-Erfurth U, Bolz M. Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems. Retina (Philadelphia, Pa). 2011;31(1):48\u201355.","journal-title":"Retina (Philadelphia, Pa)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1131-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1131-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T19:12:17Z","timestamp":1590779537000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1131-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1131-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.343\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.343\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.343\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.343\/v3","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"12 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of Shanghai General Hospital (No. 2016KY003). Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}